To examine whether CD248+CAFs mediates cisplatin chemoresistance in NSCLC through its release of IL‐8, we conducted IHC‐based IL‐8 evaluations within NSCLC and nonneoplastic tissues. This evidence concerns the gene CD248 and non-small cell lung carcinoma.